Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2019 ∙ Loperto, I. Simonetti, A. Nardone, A. Triassi, M.

Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence

  • Older adults
  • Influenza
  • Economic aspects
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2019 ∙ Kostaras, D. Karampli, E. Athanasakis, K.

Vaccination against HPV virus: a systematic review of economic evaluation studies for developed countries

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2019 ∙ Adetokunboh, O. O. Ndwandwe, D. Awotiwon, A. Uthman, O. A. Wiysonge, C. S.

Vaccination among HIV-infected, HIV-exposed uninfected and HIV-uninfected children: a systematic review and meta-analysis of evidence related to vaccine efficacy and effectiveness

  • Africa
  • Newborn
  • Children
  • Adolescents
  • Rotavirus
  • Pneumococcal disease
  • Haemophilus influenzae type B
  • Tuberculosis
  • Hepatitis B
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Masters, N. B. Wagner, A. L. Boulton, M. L.

Vaccination timeliness and delay in low- and middle-income countries: a systematic review of the literature, 2007-2017

  • Newborn
  • Children
  • Parents/caregivers
  • Low and Middle Income Countries
  • Coverage
  • Acceptance
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2019 ∙ Madeddu, G. Vroling, H. Oordt-Speets, A. Babudieri, S. O'Moore, E. Noordegraaf, M. V. Monarca, R. Lopalco, P. L. Hedrich, D. Tavoschi, L.

Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries

  • Europe
  • Adults
  • Older adults
  • Hepatitis B
  • Hepatitis A
  • Influenza
  • Measles
  • Mumps
  • Rubella
  • Acceptance
  • Coverage
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2019 ∙ Macklin, G. R. Grassly, N. C. Sutter, R. W. Mach, O. Bandyopadhyay, A. S. Edmunds, W. J. O'Reilly, K. M.

Vaccine schedules and the effect on humoral and intestinal immunity against poliovirus: a systematic review and network meta-analysis

  • Newborn
  • Poliomyelitis
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Soares-Weiser, K. Bergman, H. Henschke, N. Pitan, F. Cunliffe, N.

Vaccines for preventing rotavirus diarrhoea: Vaccines in use

  • Newborn
  • Children
  • Rotavirus
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2019 ∙ Aziminia, N. Hadjipavlou, M. Philippou, Y. Pandian, S. S. Malde, S. Hammadeh, M. Y.

Vaccines for the prevention of recurrent urinary tract infections: a systematic review

  • Adults
  • Older adults
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2019 ∙ Hill, M. C. Salmon, D. Aitken, L. M.

What are the beliefs and perceptions of practice nurses' influence about the uptake of the measles, mumps, and rubella vaccine?: An integrative literature review

  • All age groups
  • Healthcare workers
  • Mumps
  • Measles
  • Rubella
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2018 ∙ Schwerdtle, P. Onekon, C. K. Recoche, K.

A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks

  • All age groups
  • Cholera
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...